CARM Company Profile and Key Details

Q: Who are the executives of CARM?

Mr. Saar Gill M.D., Ph.D.Co-FounderMr. Richard S. Morris CPAChief Financial Officer, Chief Compliance Officer, Treasurer, Prin. Financial Off. & Prin. Acc. Off.Mr. Steven KellyPres, Chief Executive Officer & DirectorMr. Michael Klichinsky Ph.D., Pharm.D., PharmDCo-Founder & Chief Scientific OfficerMr. Tom WiltonChief Bus. OfficerMs. Terry ShieldsSenior Vice President of HRMr. Eric H. Siegel J.D., MBAGen. Counsel & Corporation Sec.

OTC : CARM

Carisma Therapeutics

$0.00

-0.0001-12.50%

Open: 1:29 PM

64.84

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Carisma Therapeutics, Inc. (CARM) stock declined over -12.50%, trading at $0.00 on OTC, down from the previous close of $0.00. The stock opened at $0.00, fluctuating between $0.00 and $0.00 in the recent session.

Stock Snapshot

0.0008

Prev. Close

29.29K

Market Cap

0.0007

Day Low

N/A

P/E Ratio

0.31

EPS (TTM)

-2.04

Cash Flow per Share

Open

41.85M

Number of Shares

0.0007

Day High

58.68%

Free Float in %

0.66

Book Value

500

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 18, 2026	0.00	0.00	0.00	0.00	500
Sep 17, 2026	0.00	0.00	0.00	0.00	4.17K
Sep 14, 2026	0.00	0.00	0.00	0.00	562
Sep 11, 2026	0.00	0.00	0.00	0.00	12.6K
Sep 10, 2026	0.00	0.00	0.00	0.00	1.04K
Sep 09, 2026	0.00	0.00	0.00	0.00	1.53K
Sep 08, 2026	0.00	0.00	0.00	0.00	2.24K
Sep 04, 2026	0.00	0.00	0.00	0.00	992
Sep 03, 2026	0.00	0.00	0.00	0.00	4.54K
Sep 02, 2026	0.00	0.00	0.00	0.00	6.21K
Sep 01, 2026	0.00	0.00	0.00	0.00	7.75K
Aug 31, 2026	0.00	0.00	0.00	0.00	24.38K
Aug 28, 2026	0.00	0.00	0.00	0.00	3.25K
Aug 27, 2026	0.00	0.00	0.00	0.00	37.55K
Aug 26, 2026	0.00	0.00	0.00	0.00	168
Aug 24, 2026	0.00	0.00	0.00	0.00	126
Aug 20, 2026	0.00	0.00	0.00	0.00	752
Aug 19, 2026	0.00	0.00	0.00	0.00	2.06K
Aug 18, 2026	0.00	0.00	0.00	0.00	2K
Aug 17, 2026	0.00	0.00	0.00	0.00	17.67K

Contact Details

Philadelphia, PA 19104

United States

https://www.carismatx.com 484 899 0326

About Company

Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidates include CT-2401, which is in preclinical trial for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others. In addition, it develops in vivo CAR-M cell therapy to treat solid tumors, including hepatocellular carcinoma. Carisma Therapeutics, Inc. has collaboration and license agreement with ModernaTX, Inc. to address oncology gene therapies. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. Carisma Therapeutics, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Frequently Asked Questions

What is the current Carisma Therapeutics, Inc. (CARM) stock price?

Carisma Therapeutics, Inc. (OTC: CARM) stock price is $0.00 in the last trading session. During the trading session, CARM stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in CARM stock occurred in the recent session was -12.5% while the dollar amount for the price change in CARM stock was - $0.00.

CARM's industry and sector of operation?

The OTC listed CARM is part of Biotechnology industry that operates in the broader Healthcare sector. Carisma Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CARM?

Mr. Saar Gill M.D., Ph.D.
Co-Founder
Mr. Richard S. Morris CPA
Chief Financial Officer, Chief Compliance Officer, Treasurer, Prin. Financial Off. & Prin. Acc. Off.
Mr. Steven Kelly
Pres, Chief Executive Officer & Director
Mr. Michael Klichinsky Ph.D., Pharm.D., PharmD
Co-Founder & Chief Scientific Officer
Mr. Tom Wilton
Chief Bus. Officer
Ms. Terry Shields
Senior Vice President of HR
Mr. Eric H. Siegel J.D., MBA
Gen. Counsel & Corporation Sec.

How CARM did perform over past 52-week?

CARM's closing price is 600% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.33 is -99.79%.

How many employees does CARM have?

Number of CARM employees currently stands at 46.

Link for CARM official website?

Official Website of CARM is: https://www.carismatx.com

How do I contact CARM?

CARM could be contacted at phone 484 899 0326 and can also be accessed through its website. CARM operates from 3675 Market Street, Philadelphia, PA 19104, United States.

How many shares of CARM are traded daily?

CARM stock volume for the day was 500 shares. The average number of CARM shares traded daily for last 3 months was 12.3K.

What is the market cap of CARM currently?

The market value of CARM currently stands at $29.29K with its latest stock price at $0.00 and 41.85M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	46
Beta	-9.03
Sales or Revenue	$14.92M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	46
Beta	-9.03
Sales or Revenue	$14.92M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

CARM Company Profile and Key Details

Carisma Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Dividend & Fair Value

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Price Forecast & Outlook

Key Takeaways

Company Overview